COLACE


What it isAnionic surfactant marketed to soften stool; constipation prevention and treatment.
Why this oneDespite entrenched use, controlled trials have not shown meaningful benefit over placebo.
What limits it⚑ Minimal toxicity is its main virtue; do not let it displace an effective osmotic or stimulant laxative.
Animated chart of estimated U.S. prescriptions per year, Constipation meds (1900–2026). Docusate enters in 1954 (estimated).
Principal riskIt performs no better than placebo
Defining liabilityGastrointestinal irritation and electrolyte loss with excessive use
Read the full label on DailyMed ↗
NO BOXED WARNINGS
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Occasional constipation (stool softener; bowel movement generally in 12–72 h) | ≥12 yr | 1–3 capsules daily (single dose or divided) | 1–3 capsules daily | 3 capsules/day |
| Occasional constipation | 2 to <12 yr | 1 capsule daily | 1 capsule daily | 1 capsule/day |
Renal Undefined
Hepatic Undefined
Do not use a stool softener laxative for more than 1 week
Available strengths
Pregnancy If pregnant, ask a health professional before use.
Lactation If breast-feeding, ask a health professional before use.
| Strength | #/mo | generic $/mo | brand $/mo | CostPlus | |
|---|---|---|---|---|---|
| 50 mg | cap | 30 qd | — | $7.69 | not offered |
| 100 mg | cap | 30 qd | $0.83 | — | not offered |
| 240 mg | cap | 30 qd | — | not offered | |
| 250 mg | cap | 30 qd | $1.57 | — | not offered |
Available combined with: senna / docusate
Open Docusate in the interactive console ↗

Open Docusate in the interactive console ↗